Table 5.
Term | Pathway | Count | P-value |
---|---|---|---|
hsa05200 | Pathways in cancer | 63 | 7.08E − 29 |
hsa05161 | Hepatitis B | 41 | 3.98E − 28 |
hsa05205 | Proteoglycans in cancer | 40 | 2.03E − 21 |
hsa04151 | PI3K-Akt signalling pathway | 47 | 3.49E − 18 |
hsa05321 | Inflammatory bowel disease (IBD) | 23 | 4.21E − 18 |
hsa05142 | Chagas disease (American trypanosomiasis) | 27 | 2.51E − 17 |
hsa05215 | Prostate cancer | 25 | 5.12E − 17 |
hsa04380 | Osteoclast differentiation | 29 | 1.17E − 16 |
hsa05210 | Colorectal cancer | 21 | 6.18E − 16 |
hsa04668 | TNF signalling pathway | 26 | 7.14E − 16 |